無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界における過敏性腸症候群関連の提携契約動向

Global Irritable Bowel Syndrome Partnering 2012-2018

発行 Current Partnering, a division of Wildwood Ventures Limited 商品コード 357459
出版日 ページ情報 英文 150+ Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.61円で換算しております。
Back to Top
世界における過敏性腸症候群関連の提携契約動向 Global Irritable Bowel Syndrome Partnering 2012-2018
出版日: 2018年09月01日 ページ情報: 英文 150+ Pages
概要

当レポートでは、世界のヘルスケア業界における過敏性腸症候群に関連する各種提携契約の動向について調査しており、近年締結された各種契約の動向、大規模契約および大手事業者による契約の概要、契約区分・開発段階・治療分野・技術領域別の一覧などをまとめています。

第1章 数値で見る提携の動向

  • 提携件数:年別
  • 提携件数:最も積極的な企業
  • 提携件数:産業部門別
  • 提携件数:契約タイプ別
  • 提携件数:技術タイプ別
  • 提携件数:開発段階別

第2章 最も積極的な企業

第3章 提携契約ディレクトリ

  • 企業別 (A-Z)
  • 契約規模 (金額) 別
  • 産業部門別
  • 契約タイプ別
  • 開発段階別
  • 技術領域別

第4章 提携契約・契約文書

第5章 数値で見るM&A

  • M&A件数:年別

第6章 M&A契約ディレクトリ

  • 企業別 (A-Z)
  • 契約規模 (金額) 別

第7章 数値で見る融資契約

  • 契約件数:年別
  • 契約件数:融資タイプ別

第8章 融資契約ディレクトリ

  • 企業別 (A-Z)
  • 契約規模 (金額) 別
  • 融資タイプ別

Wildwood Venturesについて

目次
Product Code: CP2214irr

Provides understanding and access to the irritable bowel syndrome partnering deals and agreements entered into by the worlds leading healthcare companies.

The Global Irritable Bowel Syndrome Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies.

  • Trends in partnering deals
  • Top deals by value
  • Deals listed by company A-Z, industry sector, stage of development, technology type

The report provides understanding and access to the partnering deals and agreements entered into by the world's leading healthcare companies.

The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not.

This data driven report contains multiple links to online copies of actual deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

The initial chapters of this report provide an orientation of partnering trends.

Chapter 1 provides an overview of the trends in partnering since 2012, including a summary of deals by industry sector, stage of development, deal type, and technology type.

Chapter 2 provides a review of the top 10 most active companies in the therapy area, including a comprehensive listing of the deals announced by each company.

Chapter 3 provides a comprehensive directory of partnering deals signed and announced since 2012. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.

Chapter 4 provides a listing of partnering deals where a contract document is available alongside the deal record.

Chapters 5 and 6 provide a summary of M&A deals since 2012 where the acquired company is active in the therapy area of interest.

Chapters 7 and 8 provide a summary of financings since 2012 where the financed company is active in the therapy area of interest.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products in the therapy area.

Benefits

Global Irritable Bowel Syndrome Partnering Terms and Agreements since 2012 report provides the reader with the following key benefits:

  • In-depth understanding of deal trends since 2012
  • Access to headline, upfront, milestone and royalty data
  • Comprehensive access to multiple deals entered into by the world's biopharma companies since 2012
  • Insight into key deal terms included in contracts, where disclosed
  • Understand the key deal terms companies have agreed in deals
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Table of Contents

Executive Summary

Chapter 1 - Therapypartnering trends in numbers

  • Partnering in numbers - by year
  • Partnering in numbers - most active
  • Partnering in numbers - by industry sector
  • Partnering in numbers - by deal type
  • Partnering in numbers - by technology type
  • Partnering in numbers - by stage of development

Chapter 2 - Most active dealmakers

Chapter 3 - Partnering deals directory

  • Partnering deals directory - by company A-Z
  • Partnering deals directory - by deal value
  • Partnering deals directory - by industry sector
  • Partnering deals directory - by deal type
  • Partnering deals directory - by stage of development
  • Partnering deals directory - by technology area

Chapter 4 - Partnering deals with a contract document

  • About Wildwood Ventures
  • Current Partnering
  • Current Agreements
  • Recent titles from CurrentPartnering

TABLE OF FIGURES

  • Figure 1: Partnering frequency by year
  • Figure 2: Partnering most active
  • Figure 3: Partnering by industry sector
  • Figure 4: Partnering by deal type
  • Figure 5: Partnering by technology area
  • Figure 6: Partnering by stage of development
Back to Top